Similar companies
| Company | Business Outlook | |
|---|---|---|
 |
AmgenAMGN |
77 0% |
 |
Gilead SciencesGILD |
60 3.4% |
 |
Catalyst PharmaceuticalsCPRX |
100 0% |
 |
Inovio PharmaceuticalsINO |
23 0% |
 |
Anavex Life SciencesAVXL |
0 0% |
Month over Month
Employee view on business outlook (0 - 100)
| Nov 2024 | 7 | |
| Oct 2024 | 7 | |
| Sep 2024 | 8 | |
| Aug 2024 | 10 |
How do employees feel about the future at Bionano Genomics?
According to employees, the Business Outlook at Bionano Genomics is highly negative. This is reflected in the average rating of 7 out of 100, which is considered very low.
Analyzing Business Outlook, how is Bionano Genomics performing compared to its industry peers?
Bionano Genomics underperforms its industry peers when it comes to Business Outlook, ranking in the 7th percentile.
How has the business outlook at Bionano Genomics changed over the last couple of months
In recent months, Bionano Genomics' employees have reported a shift towards a more negative business outlook, suggesting declining company morale and potentially leading to decreased market competitiveness and diminished company performance.
Why is it important to track the business outlook at Bionano Genomics?
Tracking a company's business outlook is important as a positive outlook can indicate future growth and profitability and attract new talent, while a negative outlook can discourage talent and imply demotivated employees. Additionally, data shows that companies with a high business outlook tend to perform better on the stock market compared to those with a lower business outlook.
Sign up and get more insights on the business outlook at Bionano Genomics.
